Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2016-02-26 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ARCIS-SUR-AUBE (10700), Aube
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE RIBERON : revenue, balance sheet and financial ratios
PHARMACIE RIBERON is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ARCIS-SUR-AUBE (10700),
this company of category PME
shows in 2025 a net income positive of 295 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE RIBERON (SIREN 818791253)
Indicator
2025
2024
2023
2022
2021
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
295 089 €
323 760 €
349 258 €
538 839 €
463 567 €
283 244 €
280 225 €
150 496 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE RIBERON generates positive net income of 295 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 150 k€ -> 295 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
295 089 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 54%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
53.769%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
60.73%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
2025
Debt ratio
496.481
225.005
135.434
85.869
60.871
48.184
73.847
53.769
Financial autonomy
15.354
28.659
39.734
50.765
58.915
64.128
53.769
60.73
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
53.772025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average+11 pts over 3 years
In 2025, the debt ratio of PHARMACIE RIBERON (53.77) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
60.73%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Good-11 pts over 3 years
In 2025, the financial autonomy of PHARMACIE RIBERON (60.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 308.29. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
308.291
Liquidity indicators evolution PHARMACIE RIBERON
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2021
2022
2023
2024
2025
Liquidity ratio
203.734
378.818
461.507
396.101
527.738
543.441
323.374
308.291
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
308.292025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Excellent
In 2025, the liquidity ratio of PHARMACIE RIBERON (308.29) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE RIBERON in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE RIBERON is estimated at
4 687 523 €
(range 3 180 975€ - 7 355 370€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3180k€4687k€7355k€
4 687 523 €Range: 3 180 975€ - 7 355 370€
NAF 5 année 2025
Valuation method used
Net Income Multiple
295 089 €
×
15.9x
=4 687 524 €
Range: 3 180 976€ - 7 355 370€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE RIBERON with other companies in the same sector:
Frequently asked questions about PHARMACIE RIBERON
What is the revenue of PHARMACIE RIBERON ?
The revenue of PHARMACIE RIBERON is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE RIBERON profitable?
Yes, PHARMACIE RIBERON generated a net profit of 295 k€ in 2025.
Where is the headquarters of PHARMACIE RIBERON ?
The headquarters of PHARMACIE RIBERON is located in ARCIS-SUR-AUBE (10700), in the department Aube.
Where to find the tax return of PHARMACIE RIBERON ?
The tax return of PHARMACIE RIBERON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE RIBERON operate?
PHARMACIE RIBERON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart